Not available in the U.S.
Voglibose
BASEN
What it isVoglibose is an alpha-glucosidase inhibitor that delays intestinal digestion of complex carbohydrates to blunt postprandial glucose excursions.
Why this oneUsed mainly in Japan and other Asian countries as an adjunct for type 2 diabetes and impaired glucose tolerance.
What limits itIt commonly causes flatulence, abdominal distension, and diarrhea, and is not marketed in the United States.
NO BOXED WARNINGS
Principal riskNo FDA boxed warning.
Classes and tags
Clinical profile
Open Voglibose in the interactive console ↗
Self-check
- How does voglibose blunt postprandial glucose?
Delays intestinal complex-carbohydrate digestion. - Is voglibose marketed in the United States?
No.